Can AI Help Locate Low-Cost Cancer Treatments? These Funders Want to Find Out

Can AI Help Locate Low-Cost Cancer Treatments? These Funders Want to Find Out

We can't have too many ways to fight cancer. Here’s who’s backing a nonprofit startup that’s using AI to repurpose generic drugs that could mean the difference between life and death for patients — and solvency or bankruptcy.

Read More

“A Period of Rapid Change.” How the ALS Association Shepherded a New Treatment to Market

“A Period of Rapid Change.” How the ALS Association Shepherded a New Treatment to Market

The FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.

Read More

Hot Zone: How a Drugmaker is Taking on HIV/AIDS in the South

Hot Zone: How a Drugmaker is Taking on HIV/AIDS in the South

Gilead Sciences is a leading player in HIV/AIDS funding in the U.S. South, with a major grantmaking program aimed at tackling an epidemic that’s still raging in this part of the country. Where’s the money going?

Read More